Whole blood resuscitation and post-traumatic organ dysfunction in injured children

Erin V Feeney1, Madelyn A Scarmack2, Leah M Furman1

  • 1Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Transfusion
|March 13, 2026
PubMed

Insights

Early whole blood (WB) transfusion in pediatric trauma patients may reduce organ dysfunction compared to component therapy (CT). Further research is needed to confirm the clinical benefits of WB resuscitation.

Area of Science:

  • Pediatric Critical Care Medicine
  • Trauma Resuscitation
  • Blood Transfusion Therapy

Background:

  • Whole blood (WB) and component therapy (CT) are used for hemostatic resuscitation in pediatric trauma.
  • The comparative effectiveness of early WB versus CT in reducing post-traumatic organ dysfunction is unclear.

Purpose of the Study:

  • To investigate the association between early whole blood transfusion and post-traumatic organ dysfunction in children.
  • To compare the outcomes of WB resuscitation versus CT alone in injured pediatric patients.

Main Methods:

  • Single-center observational study of children (0-17 years) with trauma and ICU admission.
  • Primary outcome: Pediatric Logistic Organ Dysfunction 2 (PELOD-2) score (days 1-7).
  • Linear regression analysis adjusted for covariates including injury severity and transfusion volume.

Main Results:

  • Of 540 subjects, 52 received transfusion within 4 hours.
  • Transfusion of WB plus other products was associated with lower PELOD-2 scores compared to RBC plus other products.
  • WB alone or RBC alone groups were smaller and not directly compared in adjusted analysis.

Conclusions:

  • Receipt of any whole blood (WB) versus component therapy (CT) alone for hemostatic resuscitation was associated with reduced organ dysfunction in transfused pediatric trauma patients.
  • Further large-scale studies are required to confirm clinical benefits and understand mechanisms.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
646
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
937